Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Regenerative MedicineCell Therapy

PUBLISHER: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | PRODUCT CODE: 1873151

Cover Image

PUBLISHER: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | PRODUCT CODE: 1873151

Autologous Cell Therapies

PUBLISHED:
PAGES: 194 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5850
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Autologous Cell Therapies Market to Reach US$78.1 Billion by 2030

The global market for Autologous Cell Therapies estimated at US$28.9 Billion in the year 2024, is expected to reach US$78.1 Billion by 2030, growing at a CAGR of 18.0% over the analysis period 2024-2030. Neurology Application, one of the segments analyzed in the report, is expected to record a 18.5% CAGR and reach US$26.1 Billion by the end of the analysis period. Growth in the Orthopedic Application segment is estimated at 17.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.1 Billion While China is Forecast to Grow at 17.1% CAGR

The Autologous Cell Therapies market in the U.S. is estimated at US$8.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$11.8 Billion by the year 2030 trailing a CAGR of 17.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.9% and 15.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.9% CAGR.

Global Autologous Cell Therapies Market - Key Trends and Drivers Summarized

Why Are Autologous Cell Therapies Transforming Personalized Medicine?

Autologous cell therapies are at the forefront of personalized medicine, offering a groundbreaking approach to treating a wide range of diseases by using a patient’s own cells. Unlike traditional therapies that use donor cells or synthetic materials, autologous therapies involve harvesting cells from a patient, modifying or expanding them in a laboratory, and then reintroducing them into the patient’s body. This process significantly reduces the risk of immune rejection, as the body recognizes the cells as its own. Autologous cell therapies are particularly promising in areas such as oncology, where treatments like CAR-T cell therapy have shown remarkable success in treating certain types of blood cancers. These therapies are also being explored for regenerative medicine applications, such as repairing damaged tissues in conditions like heart disease, spinal cord injuries, and autoimmune disorders. The ability to tailor treatments to individual patients is driving a paradigm shift in how complex diseases are managed, moving from a one-size-fits-all approach to more customized, effective interventions.

How Are Technological Advancements Enhancing Autologous Cell Therapies?

Technological advancements are playing a critical role in enhancing the efficacy and scalability of autologous cell therapies. Innovations in gene editing technologies, such as CRISPR-Cas9, have enabled precise modifications to a patient’s cells, allowing for more targeted and effective treatments. Additionally, advancements in cell culture techniques and bioreactor designs have improved the ability to expand cells ex vivo (outside the body) in a controlled environment, ensuring that a sufficient quantity of high-quality cells can be produced for therapeutic use. The development of automated cell processing systems is also streamlining the manufacturing process, reducing the time and cost associated with producing autologous cell therapies. Furthermore, next-generation sequencing and advanced diagnostic tools are being integrated into the development pipeline, enabling a better understanding of how individual patients are likely to respond to these therapies. These technological innovations are not only improving the outcomes of autologous cell therapies but are also making them more accessible to a broader patient population.

What Challenges Are Shaping the Adoption of Autologous Cell Therapies?

Despite their potential, the adoption of autologous cell therapies faces several challenges, particularly related to manufacturing, logistics, and regulatory oversight. The personalized nature of these therapies requires highly specialized manufacturing processes that are both time-consuming and expensive. Each therapy is custom-made for the individual patient, which means that scaling up production is significantly more complex than for traditional pharmaceuticals. Moreover, the logistics of transporting cells between the clinic and the manufacturing facility-and then back to the patient-pose additional challenges, including maintaining cell viability and ensuring timely delivery. Regulatory bodies are also navigating the complexities of approving these therapies, as the highly individualized nature of autologous treatments requires new frameworks for evaluating safety and efficacy. The high cost of these therapies, combined with reimbursement challenges, further complicates their adoption, particularly in markets where healthcare budgets are constrained. Addressing these challenges is essential for the broader adoption and success of autologous cell therapies in the clinical setting.

What Is Driving the Growth in the Autologous Cell Therapies Market?

The growth in the autologous cell therapies market is driven by several factors that are collectively advancing the adoption and development of these innovative treatments. One of the primary drivers is the increasing incidence of chronic and complex diseases, such as cancer and autoimmune disorders, which are not adequately addressed by conventional treatments. The success of early clinical trials, particularly in oncology, has also fueled investment and interest in expanding the applications of autologous therapies. Technological advancements, including improvements in gene editing, cell expansion, and automated manufacturing, are making these therapies more viable and scalable, further driving market growth. Additionally, the rising demand for personalized medicine and the growing recognition of the potential of autologous cell therapies to provide more effective and tailored treatments are contributing to their adoption. Regulatory support and the establishment of clearer pathways for approval are also playing a crucial role in accelerating market growth. Finally, increased collaboration between biopharmaceutical companies, research institutions, and healthcare providers is fostering innovation and expanding the reach of these therapies to more patients worldwide.

SCOPE OF STUDY:

The report analyzes the Autologous Cell Therapies market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Source (Bone Marrow, Epidermis, Other Sources); Application (Neurology, Orthopedic, Cancer, Wound Healing, Other Applications); End-Use (Hospitals, Ambulatory Centers, Research Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • BioTime, Inc.
  • Brainstorm Cell Therapeutics, Inc.
  • Caladrius Biosciences, Inc.
  • Fibrocell Science, Inc.
  • Opexa Therapeutics, Inc.
  • Pharmicell Co., Ltd.
  • Regeneus Ltd.
  • TiGenix NV
  • TxCell S.A.
  • U.S. Stem Cell, Inc.
  • Vericel Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP10422

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Autologous Cell Therapies - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Diseases Spurs Growth in Autologous Cell Therapies Market
    • Technological Advancements in Gene Editing Propel Innovation in Autologous Cell Therapies
    • Growing Demand for Personalized Medicine Expands Addressable Market for Autologous Cell Therapies
    • Increasing Investment in Biopharmaceutical Research Drives Adoption of Autologous Cell Therapies
    • Expansion of Therapeutic Applications for Autologous Therapies Drives Market Adoption
    • Growing Recognition of Autologous Therapies in Oncology Throws the Spotlight on New Treatments
    • Advancements in Cell Culture Techniques Sustain Growth in the Autologous Therapies Market
    • Next-Generation Sequencing and Diagnostics Propel Adoption of Autologous Cell Therapies
    • Growing Focus on Immune Disorders Expands Market Potential for Autologous Therapies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Bone Marrow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Bone Marrow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Bone Marrow by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Epidermis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Epidermis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Epidermis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Other Sources by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Other Sources by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Other Sources by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Orthopedic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Orthopedic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Orthopedic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Wound Healing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Wound Healing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Wound Healing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Ambulatory Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Ambulatory Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Ambulatory Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 34: World Autologous Cell Therapies Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Autologous Cell Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Autologous Cell Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Autologous Cell Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Autologous Cell Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Autologous Cell Therapies by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Autologous Cell Therapies by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Autologous Cell Therapies by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Autologous Cell Therapies by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Autologous Cell Therapies by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Autologous Cell Therapies by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Autologous Cell Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Autologous Cell Therapies by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Autologous Cell Therapies by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Autologous Cell Therapies by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Autologous Cell Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Autologous Cell Therapies by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Autologous Cell Therapies by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Autologous Cell Therapies by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Autologous Cell Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Autologous Cell Therapies by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Autologous Cell Therapies by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Autologous Cell Therapies by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Autologous Cell Therapies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Autologous Cell Therapies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Autologous Cell Therapies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Autologous Cell Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Autologous Cell Therapies by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Autologous Cell Therapies by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Autologous Cell Therapies by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Autologous Cell Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Autologous Cell Therapies by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Autologous Cell Therapies by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Autologous Cell Therapies by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Autologous Cell Therapies by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Autologous Cell Therapies by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Autologous Cell Therapies by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Autologous Cell Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Autologous Cell Therapies by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Autologous Cell Therapies by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Autologous Cell Therapies by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Autologous Cell Therapies by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 15-Year Perspective for Autologous Cell Therapies by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Autologous Cell Therapies by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Autologous Cell Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Autologous Cell Therapies by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2015, 2025 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 15-Year Perspective for Autologous Cell Therapies by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Autologous Cell Therapies by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Autologous Cell Therapies by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of World 15-Year Perspective for Autologous Cell Therapies by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of World 15-Year Perspective for Autologous Cell Therapies by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!